A model system for antiviral siRNA therapeutics using exosome-based delivery

Mostrar otras versiones (1)

Emerging viral diseases, such as Ebola, SARS, MERS, and the pathogen causing COVID-19, SARS-CoV-2, present a challenge for the development of therapeutics because of strict biosafety handling procedures and rapid mutation of their genomes. To facilitate the development of an adaptable and testable t...

Descripción completa

Detalles Bibliográficos
Autores principales: Wallen, Margaret, Aqil, Farrukh, Kandimalla, Raghuram, Jeyabalan, Jeyaprakash, Auwardt, Supipi, Tyagi, Neha, Schultz, David J., Spencer, Wendy, Gupta, Ramesh C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9384066/
https://www.ncbi.nlm.nih.gov/pubmed/35992044
http://dx.doi.org/10.1016/j.omtn.2022.08.011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9384066/
https://www.ncbi.nlm.nih.gov/pubmed/35992044
http://dx.doi.org/10.1016/j.omtn.2022.08.011

Ejemplares similares